Pulse Archives

2011

• | 1.1.11 | Recent Market Trends are the New Market Reality
  HTML version, PDF version

2010

• | 10.21.10 | Pivot to Succeed
  HTML version, PDF version
  
  
• | 1.8.10 | Trends 2010
  HTML version, PDF version

2009

• | 12.10.09 | Advice to Medical Device Companies: "Don't Go It Alone!"
  HTML version, PDF version
  
  
• | 10.01.09 | Addendum: "Hello Europe. Be the First to Meet My New Product."
  HTML version, PDF version
  
  
• | 08.25.09 | "Hello Europe. Be the First to Meet My New Product." When is crossing the Atlantic the best way to introduce your pharmaceutical or medical device?
  HTML version, PDF version
  
  
• | 04.30.09 | Preventing Bloody Noses and Cold Feet:  What European Life Science Companies Should Know about US Marketing.
  HTML version, PDF version
  
  
• | 02.18.09 | Curing the Plague of Over-Eager Product Licensing.
  HTML version, PDF version
  

2008

• | 09.16.08 | Don't Trust Your Gut. It Lies.
  HTML version, PDF version
  
  
• | 06.13.08 | The U.S. Market: “Treasure Chest or Trap” for Foreign Life Science Companies?
  HTML version, PDF version

• | 03.31.08 |  Steroid Marketing.Giving New Products a Better Competitive Edge
  HTML version , PDF version

• | 01.17.08 |  Kicking Off 2008. Market Insights for Life Science Professionals
  HTML version, PDF version

2007

• | 10.26.07 | Market Development in the Life Sciences Industry
  HTML version, PDF version

• | 08.26.07 |  Building Sustainable Brand Value with Key Thought Leaders
  HTML version , PDF version

• | 06.26.07 | Maximizing Value in a Reimbursement Sensitive Market
  HTML version , PDF version
  

• | 03.22.07 | How Private Equity Funds Can Boost the Value of Your Medical Device or Biopharma Company
  HTML version, PDF version

• | 03.22.07 | Big Pharma is Broken: Long Live Specialty Pharma
  HTML version, PDF version

• | 02.22.07 | How to Right Size an Oversized Sales Force
  HTML version, PDF version

• | 02.22.07 | Medicare Part D: Deal with Pricing "What If's" Now
  HTML version, PDF version

• | 02.22.07 | Avoid Sticker Shock: Work with Payors Prior to Launch
  HTML version, PDF version

• | 01.23.07 | Product Licensing Partnerships: Don't Try This at Home
  HTML version, PDF version

• | 01.23.07 | Higher Goal for Phase 3 Trials: Answer the How To's and What If's
  HTML version, PDF version

• | 01.23.07 | Early Stage/Late Stage Products: Focus on 4 P's
  HTML version, PDF version

2006

• | 11.21.06 | Maximizing ROI in Your Sales Force
  HTML version, PDF version

• | 11.21.06 | Clinical Trials: Not Just for Registration
  HTML version, PDF version

• | 11.21.06 | Nearer Term Deals and Higher Valuations
  HTML version, PDF version

• | 10.02.06 | Launching Products Into Managed Care Markets: New Value Creation
  HTML version, PDF version

• | 10.02.06 | Fuel Your New Product Plans: New Money for Breakthrough Deals
  HTML version, PDF version

• | 10.02.06 | Win-Win Investments in Key Opinion Leader Programs
  HTML version, PDF version